Mary Woolley

Dear Research Advocate, American achievement continues to astound. This week we watched NASA’€™s Jet Propulsion Laboratory send one of the most advanced space exploration vehicles ever constructed to a planet hundreds of millions of miles away from Earth and elegantly deliver it to the planet’€™s surface. Mars today, why not a cure for our nation’€™s deadliest diseases tomorrow? As advocates, we cannot take no for answer when it comes to assuring we have the resources, policies and determination we need to defeat disease and disability. Why should we be reluctant to demand that this be a national priority? As Margaret Mead once said, ’€œNever doubt that a small group of thoughtful,...
WASHINGTON’€”August 7, 2012 ’€” Research!America, a nonprofit advocacy alliance, says too many congressional candidates are minimizing the importance of our nation’€™s faltering role in fighting deadly and disabling diseases as a campaign issue. Polling indicates that Americans rank medical research a high priority but also shows a majority of likely voters are not aware of their representatives’€™ views on research. Some candidates have indicated that they ’€œdon’€™t have time’€ to fill out a short questionnaire gauging their views on the importance of continued medical progress. Research!America and its partner organizations are calling on candidates to elevate the fight to save lives in...
Research!America President and CEO Mary Woolley released a statement, saying that a House appropriations subcommittee bill places the health and well-being of Americans in jeopardy: “How can Congress justify the elimination of a critical health agency and severe cuts to other programs under the House Labor-HHS-Education appropriations subcommittee bill? We cannot afford to zero out funding for the Agency for Healthcare Research and Quality (AHRQ) at a time when it is addressing medical errors that kill more than 100,000 people a year and accelerating patient access to the best medical practices. We cannot afford to slash the Centers for Disease Control and Prevention (CDC) budget when it...
Dear Research Advocate, What do sequencing and sequestration have in common, besides being mysterious words to most people? It’€™s pretty simple: We won’€™t have more of the former if the latter takes place. Why isn’€™t it a Sputnik moment to learn that there is more sequencing capacity at Beijing Genome Institute than we have total capacity in our country? And, to learn that the Chinese government is subsidizing the cost of sequencing so that it is fast becoming the go-to place for industry and academia worldwide? It’€™s time for advocates to talk this up so that policy makers will once again plus-up research as a U.S. priority. Jeffrey Zients, the Acting Director of the White House Office...
Dear Research Advocate, As we celebrate our nation’€™s birthday week, it’€™s worth taking a moment to reflect on the role of American research and innovation in driving American prosperity and making tremendous health advances possible. For policy makers and the public alike, it is simply too easy to become complacent and lose sight of the role research has played in powering new industries, lengthening our lives and reducing disability. Indeed, many people have become complacent about progress, so that we no longer hear about the urgency of HIV/AIDS research, for example; yet we can’€™t shy away now from the work that is left to do. That’€™s one of the take-home messages from viewing...
The following is a statement from Research!America President and CEO Mary Woolley on the Senate’s passage of FDA user fee legislation: “Senate approval of the FDA Safety and Innovation Act demonstrates the willingness of lawmakers to prioritize the health and safety of patients. The bipartisanship displayed in crafting and moving the bill through Congress underscores the strong support for bringing lifesaving treatments to patients in a safe, efficient and speedy manner. The additional funding for review of prescription drugs and medical devices, along with key policy changes, will accelerate the approval process and address issues that have for too long disrupted the flow of innovative new...

Pages

Sidebar Quote

Public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.
Abraham Lincoln